Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Materials
/
Aspen Aerogels
ASPN
Aspen Aerogels
Rising Regulation And Capital Strains Will Weaken EV Outlook
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 6 Analysts
Published
08 May 25
Updated
16 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
US$6.00
20.8% overvalued
intrinsic discount
16 Aug
US$7.25
Loading
1Y
-75.8%
7D
-4.0%
Author's Valuation
US$6.0
20.8% overvalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
US$6.0
20.8% overvalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-312m
405m
2014
2017
2020
2023
2025
2026
2028
Revenue US$404.8m
Earnings US$47.0m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
12.67%
Chemicals revenue growth rate
0.35%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
7.82%
Calculation
US$47.02m
Earnings '28
x
16.00x
PE Ratio '28
=
US$752.39m
Market Cap '28
US$752.39m
Market Cap '28
/
100.47m
No. shares '28
=
US$7.49
Share Price '28
US$7.49
Share Price '28
Discounted to 2025 @ 7.84% p.a.
=
US$5.97
Fair Value '25
